Literature DB >> 2180697

Use of fragments of hirudin to investigate thrombin-hirudin interaction.

S Dennis1, A Wallace, J Hofsteenge, S R Stone.   

Abstract

Site-directed mutagenesis was used to create hirudin in which Asn52 was replaced by methionine. Cyanogen bromide cleavage at this unique methionine resulted in two fragments. These fragments have been used to study the kinetic mechanism of the inhibition of thrombin by hirudin and to identify areas of the two molecules which interact with each other. The binding of the C-terminal fragment (residues 53-65) to thrombin resulted in a decrease in the Michaelis constant for the substrate D-phenylalanylpipecolylarginyl-p-nitroanilide (DPhe-Pip-Arg-NH-Ph). The N-terminal fragment (residues 1-52) was a competitive inhibitor of thrombin. There was a small amount of cooperativity in the binding of the two fragments. Whereas hirudin and its C-terminal fragment protected alpha-thrombin against cleavage by trypsin, the N-terminal fragment did not. Hirudin and the N-terminal fragment completely prevented the cleavage of alpha-thrombin by pancreatic elastase while the C-terminal fragment afforded a lesser degree of protection. The results of these experiments with trypsin and elastase are discussed in terms of interaction areas on thrombin and hirudin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180697     DOI: 10.1111/j.1432-1033.1990.tb15371.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

Review 1.  Hirudin, a new therapeutic tool?

Authors:  J Bichler; H Fritz
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

2.  Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.

Authors:  Matthew W Bunce; Mettine H A Bos; Sriram Krishnaswamy; Rodney M Camire
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

3.  Prediction of location of active sites in biologically active peptides.

Authors:  T Kikuchi
Journal:  J Protein Chem       Date:  1996-08

Review 4.  Rate constants and mechanisms of intrinsically disordered proteins binding to structured targets.

Authors:  Huan-Xiang Zhou; Xiaodong Pang; Cai Lu
Journal:  Phys Chem Chem Phys       Date:  2012-06-28       Impact factor: 3.676

5.  The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin.

Authors:  A van de Locht; W Bode; R Huber; B F Le Bonniec; S R Stone; C T Esmon; M T Stubbs
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

6.  Evidence for common structural changes in thrombin induced by active-site or exosite binding.

Authors:  M A Parry; S R Stone; J Hofsteenge; M P Jackman
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

7.  Allosteric modulation of the activity of thrombin.

Authors:  E J Duffy; H Angliker; B F Le Bonniec; S R Stone
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

8.  Thrombin hydrolysis of human osteopontin is dependent on thrombin anion-binding exosites.

Authors:  Timothy Myles; Lawrence L K Leung
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

Review 9.  Proton Bridging in Catalysis by and Inhibition of Serine Proteases of the Blood Cascade System.

Authors:  Ildiko M Kovach
Journal:  Life (Basel)       Date:  2021-04-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.